Skip to main content

GalNAc-L96 - A Key Molecule for Efficient RNA Targeted Delivery

Introduction to GalNAc-L96

GalNAc-L96 (CAS 1159408-62-4) is a triantennary N-acetylgalactosamine (GalNAc) ligand primarily used for the synthesis of GalNAc-siRNA. GalNAc is a specific ligand for ASGPR (Asialoglycoprotein Receptor), enabling liver-targeted delivery, which is a crucial aspect of modern RNA delivery technology.

Applications and Advantages of GalNAc-L96

  1. Precise Liver-Targeted Delivery: ASGPR is highly expressed on liver cell surfaces, allowing siRNA, antisense oligonucleotides (ASO), or other nucleic acid drugs conjugated with GalNAc-L96 to efficiently enter liver cells and enhance therapeutic effects.
  2. Enhanced Bioavailability of siRNA: Traditional siRNA delivery methods (such as lipid nanoparticles, LNPs) often lead to non-specific distribution, whereas GalNAc-conjugated siRNA (GalNAc-siRNA) enables more efficient and safer RNA interference (RNAi) therapy.
  3. Reduced Systemic Toxicity: Due to the high specificity of GalNAc delivery, compared to LNPs, GalNAc-siRNA exhibits lower immunogenicity and reduced side effects, making it a preferred strategy for RNA drug development.
  4. Improved Stability and Optimized Pharmacokinetics: By optimizing the structure of GalNAc-L96, its affinity for ASGPR can be enhanced, thereby increasing hepatic cell uptake and prolonging in vivo half-life.

Watson’s Unique Advantages in the GalNAc Field

  1. Advanced Synthesis Techniques and Purity Control
  • Watson leverages cutting-edge glycochemistry and nucleic acid modification technologies to provide high-purity, high-quality GalNAc-L96 and its derivatives, ensuring optimal outcomes in RNAi and ASO drug development.
  1. Comprehensive Support from Lab to Industrial Scale
  • Watson not only supplies small-scale research-grade products but also has pilot and industrial-scale production capabilities, meeting the demands from early-stage research to clinical production.
  • Strict adherence to quality management systems (ISO certification) ensures product quality and stability.
  1. Strong Technical Expertise and Industry Recognition
  • With years of experience in glycoconjugates and RNA delivery, Watson collaborates with leading pharmaceutical and biotechnology companies worldwide, driving advancements in RNA therapeutics.
  • Watson’s high-end customization and innovative synthesis capabilities make it a key global partner in RNA delivery technologies.

Conclusion

As a core ligand for RNA-targeted delivery, GalNAc-L96 plays a vital role in siRNA and ASO therapies. With cutting-edge synthesis technologies, strict quality control, and strong customization capabilities, Watson holds a distinct competitive advantage in this field, supporting breakthroughs in RNA delivery technology.

If you are interested in GalNAc-related products or RNA delivery solutions, feel free to contact Watson for more information!

Reference

GalNAc-L96 on Watson International

Labels:

Comments

Post a Comment

Popular posts from this blog

IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data Identification Product Namemethylammonium iodideIUPAC Namemethylazanium;iodide Molecular StructureCAS Registry Number 14965-49-2MDL NumberMFCD28100833SynonymsMethylammonium iodide14965-49-2methylazanium;iodideEINECS 239-037-4methylazanium iodideMethanamine, hydriodideMethyl ammonium iodideMethylamine.hydriodicacidSCHEMBL1534750Methylammonium Iodide, anhydrousDB-221235NS00086090Molecular FormulaCH6INMolecular Weight158.97InChIInChI=1S/CH5N.HI/c1-2;/h2H2,1H3;1HInChI KeyLLWRXQXPJMPHLR-UHFFFAOYSA-N  Canonical SMILESC. Patent InformationPatent IDTitlePublication DateWO2023/180219A METHOD FOR SYNTHESIS OF HALIDE SALTS2023CN113845428Preparation method of perovskite material powder2021WO2018/169373METHOD OF PREPARING LUMINESCENT NANO-SHEET, LUMINESCENT NANO-SHEET MATERIAL, LUMINESCENT NANO-SHEET FILM, BACK LIGHT, AND LIQUID CRYSTAL DISPLAY APPARATUS2018WO2015/32748AMORPHOUS MATERIAL AND THE USE THEREOF2018 ...
Post a Comment
Read more
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data Identification Product NameNickel HydroxideIUPAC Namenickel;dihydrate Molecular StructureCAS Registry Number 12054-48-7EINECS Number235-008-5MDL NumberMFCD00011140Beilstein Registry NumberSynonyms12054-48-7AKOS015903693CS-0089243dihydroxynickelEC 235-008-5EINECS 235-008-5HSDB 1827LS-96321MFCD00011140Nickel dihydroxideNickel hydroxide (II)Nickel hydroxide (Ni(OH)2)Nickel hydroxide (ous)Nickel Hydroxide nanowireNickel(2+) hydroxidenickel(II) dihydroxideNickel(II) hydroxide, for analysisnickel;dihydrateNickelous hydroxideUNII-L8UW92NW6JMolecular FormulaH4NiO2Molecular Weight94.724 InChIInChI=1S/Ni.2H2O/h;2*1H2 InChI KeyAIBQNUOBCRIENU-UHFFFAOYSA-N  Canonical SMILESO.O.   Physical Data AppearanceGreen powder Spectra Description (IR Spectroscopy)Solvent (IR Spectroscopy)Temperature (IR Spectroscopy), °CBandssolid matrix-258 Description (UV/VIS Spectroscopy)Solvent (UV/VIS Spectroscopy)Comment (UV/VIS Spec...
Post a Comment
Read more

A Timeless Fusion - The Lantingji Xu Bookmark produced by ChemWhat

ChemWhat has partnered with British curators and a renowned Hong Kong calligrapher to bring forth, for the very first time, a faithful copper bookmark reproduction of Feng Chengsu's Shenlong Edition of the The Preface to the Orchid Pavilion Gathering — hailed as the greatest calligraphic work under heaven and widely regarded as the Tang dynasty copy closest to Wang Xizhi's original masterpiece. https://www.youtube.com/watch?v=nl-ybtqjJho
Post a Comment
Read more